HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ovrum, E. Articles by Ringdal, M. L. Search for Related Content PubMed PubMed Citation Articles by Ovrum, E. Articles by Ringdal, M. L.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 78-83, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations

E Ovrum, E Am Holen, M Abdelnoor, R Oystese and ML Ringdal
Department of Cardiac Surgery and Anesthesiology, Oslo Heart Center, Norway.

The contribution of fibrinolysis to postoperative bleeding after cardiopulmonary bypass led to routine use of tranexamic acid, a potent antifibrinolytic drug, for a period of time. Two hundred patients undergoing elective coronary artery bypass operations were studied, one group of 100 patients given tranexamic acid (40 mg/kg) (group I) after bypass and one subsequent group of 100 patients (group II) serving as a control group. All patients were treated by the same team, and the groups were comparable in all major clinical parameters. The mean mediastinal drainage in group I was 565 +/- 239 ml versus 656 +/- 257 ml in group II. Univariate and multivariate analysis revealed statistical significance (p = 0.02) when corrected for body surface area. However, applying a consistent blood conservation protocol, including removal of autologous blood before bypass for retransfusion after bypass, returning of all oxygenator and tubing contents to the patients, and autotransfusion of the mediastinal shed blood up to 18 hours postoperatively, resulted in nearly identical hemoglobin concentration at discharge (119 +/- 14 gm/L in group I and 121 +/- 14 gm/L in group II). The prevalence of postoperative myocardial infarction included five patients in group I compared with one patient in group II. Although not statistically significant (p = 0.2), the difference is of concern. Tranexamic acid has a beneficial effect on reducing postoperative bleeding after coronary artery bypass operations. The routine use of the drug is not recommended, however, because its effect is a weak one, and it may be of potential hazard by precipitating thrombosis and eventual myocardial infarction.

This article has been cited by other articles:

				J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]

				S. Thiagarajamurthy, A. Levine, and J. Dunning Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery? Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 489 - 494. [Abstract] [Full Text] [PDF]

				H. Pleym, R. Stenseth, A. Wahba, L. Bjella, A. Karevold, and O. Dale Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery Anesth. Analg., April 1, 2003; 96(4): 923 - 928. [Abstract] [Full Text] [PDF]

				M. De Bonis, F. Cavaliere, F. Alessandrini, E. Lapenna, F. Santarelli, U. Moscato, R. Schiavello, and G. F. Possati TOPICAL USE OF TRANEXAMIC ACID IN CORONARY ARTERY BYPASS OPERATIONS: A DOUBLE-BLIND, PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 575 - 580. [Abstract] [Full Text] [PDF]

				E. Bennett-Guerrero, W. F. Spillane, W. D. White, L. H. Muhlbaier, S. A. Gall Jr, P. K. Smith, and M. F. Newman {{varepsilon}}-aminocaproic acid administration and stroke following coronary artery bypass graft surgery Ann. Thorac. Surg., May 1, 1999; 67(5): 1283 - 1287. [Abstract] [Full Text] [PDF]

				D. Royston Hemostatic Drugs in Prothrombotic or Hypercoagulable States Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 376 - 394. [Abstract] [PDF]

				Z.'e. Zonis, M. Seear, C. Reichert, S. Sett, and C. Allen THE EFFECT OF PREOPERATIVE TRANEXAMIC ACID ON BLOOD LOSS AFTER CARDIAC OPERATIONS IN CHILDREN J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 982 - 987. [Abstract] [Full Text]

				D. Katsaros, M. Petricevic, N. J. Snow, D. D. Woodhall, and R. Van Bergen Tranexamic Acid Reduces Postbypass Blood Use: A Double-Blinded, Prospective, Randomized Study of 210 Patients Ann. Thorac. Surg., April 1, 1996; 61(4): 1131 - 1135. [Abstract] [Full Text]

				B. Blauhut, W. Harringer, P. Bettelheim, J. E. Doran, P. Spath, and P. Lundsgaard-Hansen Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1083 - 1091. [Abstract] [Full Text]

				P. O. Daily, J. A. Lamphere, W. P. Dembitsky, R. M. Adamson, and N. F. Dans Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass graftingA randomized, prospective, double-blind study J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 99 - 108. [Abstract] [Full Text]

				J. Horrow, M. D. Strong, and D. F. Van Riper Tranexamic acid after bypass: Too late to help? J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1375 - 1376. [Full Text]

				I. M. Ali and R. W. Landymore The use of tranexamic acid in cardiac operations J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1377 - 1377. [Full Text]